Entities / Company
Hanmi Pharmaceutical.
South Korean pharmaceutical company
- Reports this week
- 0
- Active events
- 1
- Connections
- 16
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
-
A consortium involving Samsung SDS, Hanmi Pharmaceutical, and Air Studio received support for an AI project via a voucher program.Some support1 report
-
FDA granted Orphan Drug Designation to BAL0891, a therapeutic targeting the TTK protein, developed by Hanmi Pharmaceutical.Some support1 report
-
Hanmi Pharmaceutical, a South Korean company, successfully licensed one of its obesity drug candidates to the multinational giant Hoffmann-La Roche on August 1, 2026.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Hanmi Pharmaceutical this week
News at the entities that move Hanmi Pharmaceutical most-
Hoffmann-La Roche StructuralRoche Pharma Vietnam partners with the Bright Future Fund, which is led by Nguyen Thi Xuyen.Moves Hanmi Pharmaceutical
Connections
The 4 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Hoffmann-La Roche Structural
Hanmi Pharmaceutical holds a licensing agreement with Roche Group for its obesity drug.
-
National IT Industry Promotion Agency Structural
The government agency provides structured financial and operational support to the company via a voucher program.
-
Air Studio Structural
Hanmi Pharmaceutical utilizes Air Studio to conduct Quality Assurance operations.
-
Samsung SDS Operational
Hanmi Pharmaceutical and Samsung SDS are consortium partners collaborating on an AI project.